Back to STATE STREET CORP STATE STREET CORP

CTMXCTMX
28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CYTOMX THERAPEUTICS INC

STATE STREET CORP holds 11.7M shares of CTMX (CYTOMX THERAPEUTICS INC), worth $44.1M as of 2026-Q2. The position was increased (+107.4% shares). CTMX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$44.1M

Current Shares

11.7M

Total Value Change

+$32.7M

Total Shares Change

+10.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11.7M
+107.4%
$44.1M0.0%$3.75
47
2026-Q1
Increased
5.7M
+10.2%
$26.6M0.0%$4.70
32
2025-Q4
Increased
5.1M
+697.1%
$21.9M0.0%$4.26
46
2025-Q3
Increased
644,982
+0.9%
$2.1M0.0%$3.19
26
2025-Q2
Increased
639,040
+99.7%
$1.5M0.0%$2.27
41
2025-Q1
Unchanged
320,043
0.0%
$203,4830.0%$0.64
0
2024-Q4
Increased
320,043
+21.4%
$329,6440.0%$1.03
19
2024-Q3
Unchanged
263,643
0.0%
$311,0990.0%$1.18
0
2024-Q2
Decreased
263,643
-1.4%
$321,6440.0%$1.22
0
2024-Q1
Unchanged
267,476
0.0%
$583,0980.0%$2.18
0
2023-Q4
Unchanged
267,476
0.0%
$414,5880.0%$1.55
0
2023-Q3
Unchanged
267,476
0.0%
$345,0440.0%$1.29
0
2023-Q2
Unchanged
267,476
0.0%
$460,0590.0%$1.72
0
2023-Q1
Increased
267,476
+19.4%
$403,8890.0%$1.51
19
2022-Q4
Unchanged
223,976
0.0%
$358,3620.0%$1.60
0
2022-Q3
Unchanged
223,976
0.0%
$325,0000.0%$1.45
0
2022-Q2
Decreased
223,976
-81.3%
$410,0000.0%$1.83
0
2022-Q1
Decreased
1.2M
-56.3%
$3.2M0.0%$2.67
0
2021-Q4
Decreased
2.7M
-32.1%
$11.9M0.0%$4.33
0
2021-Q3
Decreased
4M
-12.6%
$20.5M0.0%$5.09
0
2021-Q2
Increased
4.6M
+37.4%
$29.2M0.0%$6.33
38
2021-Q1
Increased
3.4M
+63.8%
$26M0.0%$7.73
42
2020-Q4
Decreased
2.1M
-4.6%
$13.4M0.0%$6.55
0
2020-Q3
Decreased
2.1M
-2.1%
$14.3M0.0%$6.65
0
2020-Q2
Increased
2.2M
+122.5%
$18.3M0.0%$8.33
46
2020-Q1
Decreased
986,948
-0.3%
$7.6M0.0%$7.67
0
2019-Q4
Decreased
989,570
-35.8%
$8.2M0.0%$8.31
0
2019-Q3
First report
1.5M
-
$11.4M0.0%$7.38
0

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used